ALTA PARTNERS II INC

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$6.98M

Insider Activity of ALTA PARTNERS II INC

The largest sale of all time was on 2004-05-03 and amounted to 95200 shares of Rigel Pharmaceuticals, Inc. for $2.03M.

Biography of ALTA PARTNERS II INC

No biography is available at this moment.

2004-05-07SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
3,100
0.0171%
$21.50$66,650-8.36%
2004-05-03SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
95,200
0.5216%
$21.31$2.03M-7.24%
2004-04-30SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
8,400
0.0462%
$21.25$178,500-5.89%
2004-04-29SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
34,800
0.1898%
$21.25$739,514-6.66%
2004-04-28SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
8,000
0.0439%
$21.25$170,000-5.95%
2004-04-27SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
7,200
0.0396%
$21.26$153,038-5.66%
2004-04-26SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
1,700
0.0094%
$21.26$36,142-4.64%
2004-04-23SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
13,100
0.0713%
$21.32$279,285-6.7%
2004-04-22SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
1,900
0.0104%
$21.25$40,375-5.47%
2004-04-21SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
6,900
0.0384%
$21.27$146,747-3.88%
2004-04-07SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
60,300
0.3279%
$21.00$1.27M-3.96%
2004-04-06SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
9,700
0.0533%
$21.00$203,700-2.96%
2004-04-05SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
1,200
0.0072%
$22.95$27,540-2.3%
2004-03-24SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
7,487
0.0485%
$20.00$149,740+7.53%
2004-02-19SaleRigel Pharmaceuticals, Inc.
RIGL
10 percent owner
74,464
0.4315%
$20.00$1.49M-3.81%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.